Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 1999

View Archived Issues

Transplanted neural stem cells compensate for missing cell types

NAVA's novel meningococcal vaccine elicits immunologic memory

More data presented on Immunomedics' infection diagnostic at medical conference

NeoRx's Pretarget technology permits higher doses of radiation in lymphoma patients

Aviron completes FluMist bridging study

Seven preclinical studies demonstrate antitumor activity of NovoMAb-G2

B7-2/GM-CSF immunogene therapy: a novel approach to the treatment of glioma

Canadian study supports efficacy of Cerebrolysin in patients with mild AD

Kos to copromote two cardiovascular drugs with Knoll

Ortec to initiate pivotal study of Composite Cultured Skin

Cerep and Tibotec initiate HIV drug discovery collaboration

Tacrine may reduce symptoms of Tourette syndrome

Regeneron meets strategic objectives in 1998

MORE trial results: raloxifene prevents breast cancer in postmenopausal women

Vinylamycin: new antibiotic discovered by Japanese research group

Schering-Plough prepares potent H3 antagonists for allergy, CNS disorders, etc.

CPMP recommends approval of DMARD

New Egis compounds lower blood pressure without marked increases in heart rate

Isoprinosine as a potential treatment for chronic fatigue syndrome

Effects on sexual function in hypertensive males: not all antihypertensives are created equal

Pharmacia & Upjohn claims new antibacterial oxazolidinones

Sankyo's olmesartan featured at European meeting

Glutamate release inhibitors, their preparation and use disclosed by Novartis

St. Elizabeth's discovers new N-acetylserotonin derivatives useful for hypertension, depression

Suntory compounds exert both lipid peroxidation- and Ca2+ overload-suppressing effects

Pharmacia & Upjohn seeks merger with Sugen

Potent and orally active human renin inhibitor selected for further study at Roche

Leukotriene antagonist effective and well tolerated as migraine prophylaxis

FDA grants orphan drug designation to PPL's AAT for congenital deficiency

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...